Clinical Trials Sponsored by Novartis Pharmaceuticals
Total 21317 results
-
Novartis PharmaceuticalsCompletedUveal MelanomaUnited Kingdom, France, Netherlands, United States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedRenal ImpairmentRussian Federation
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentUnited States
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, Russian Federation, United States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminatedDiffuse Large B-Cell LymphomaTaiwan, Netherlands, Hong Kong, Italy, Germany, United States, Spain, France, United Kingdom, Korea, Republic of
-
Novartis PharmaceuticalsCompletedChronic Heart Failure (CHF)Netherlands, Germany, Poland, United States
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, Poland, Belgium, Argentina, Russian Federation, Czechia
-
Novartis PharmaceuticalsCompletedRenal ImpairmentGermany, Bulgaria
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionBelgium, Germany, Israel, Bulgaria, United States
-
Novartis PharmaceuticalsCompletedSquamous Cell Carcinoma of Head and Neck | Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer | HER2 + Gastric CancerTaiwan, Spain, Canada, Korea, Republic of, United States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorJapan
-
Novartis PharmaceuticalsTerminatedPulmonary Fibrosis Secondary to Systemic Sclerosis
-
Novartis PharmaceuticalsCompletedAllergic RhinitisUnited States, Canada
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedProstate CancerCanada, United States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
Novartis PharmaceuticalsCompletedDiabetes | Renal ImpairmentRussian Federation
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Novartis PharmaceuticalsCompletedRenal Insufficiency | Multiple MyelomaUnited Kingdom, Spain, United States
-
Novartis PharmaceuticalsCompletedHepatocellular Carcinoma (HCC) | Solid MalignanciesUnited States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
-
Novartis PharmaceuticalsCompletedHypercholesterolemia | LDL CholesterolUnited States
-
Novartis PharmaceuticalsTerminatedHypertensionUnited States
-
Novartis PharmaceuticalsCompletedSkeletal MuscleUnited States
-
Novartis PharmaceuticalsTerminatedKidney TransplantationSpain, Germany, Switzerland, Italy, United Kingdom, France, United States, Canada
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Novartis PharmaceuticalsCompletedBreast Cancer | Solid Tumors | Cowden SyndromeUnited States, Spain, Canada
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | Castration-resistant Prostate Cancer | Uterine LeiomyomaSpain, Belgium, Italy, United States
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsTerminatedCutaneous Squamous Cell Carcinoma in Situ (CSCCis)Belgium, Australia, United States
-
Novartis PharmaceuticalsCompletedRheumatoid ArthritisGermany
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedPrimary Osteoarthritis Patients Scheduled for Total Knee Replacement SurgeryUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal CancerSpain, Italy, Singapore, Canada, Israel, Korea, Republic of, Netherlands, Australia
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedTransfusional Iron Overload | β-thalassemiaItaly
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive Chronic Myelogenous LeukemiaGermany, Canada, France, Spain, Italy